Kestra Private Wealth Services’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$939K Buy
4,819
+86
+2% +$17.8K 0.01% 934
2026
Q1
$1.06M Sell
4,733
-64
-1% -$15.9K 0.01% 812
2025
Q4
$1.16M Sell
4,797
-1,114
-19% -$285K 0.01% 742
2025
Q3
$1.62M Sell
5,911
-2,755
-32% -$753K 0.02% 598
2025
Q2
$2.24M Buy
8,666
+722
+9% +$172K 0.03% 466
2025
Q1
$1.78M Sell
7,944
-799
-9% -$187K 0.03% 486
2024
Q4
$2M Buy
8,743
+4,702
+116% +$1.13M 0.03% 432
2024
Q3
$986K Sell
4,041
-3,701
-48% -$827K 0.02% 620
2024
Q2
$1.48M Buy
7,742
+250
+3% +$50.7K 0.03% 464
2024
Q1
$1.48M Buy
7,492
+1,170
+19% +$214K 0.03% 455
2023
Q4
$1.09M Buy
6,322
+1,695
+37% +$260K 0.03% 503
2023
Q3
$684K Buy
4,627
+359
+8% +$64.9K 0.02% 566
2023
Q2
$933K Buy
4,268
+3
+0.1% +$669 0.03% 463
2023
Q1
$934K Sell
4,265
-3
-0.1% -$651 0.04% 426
2022
Q4
$888K Sell
4,268
-978
-19% -$215K 0.05% 394
2022
Q3
$1.15M Buy
5,246
+47
+0.9% +$10.7K 0.07% 311
2022
Q2
$1.09M Buy
5,199
+334
+7% +$71.1K 0.06% 329
2022
Q1
$1.18M Buy
4,865
+1,150
+31% +$278K 0.06% 337
2021
Q4
$968K Buy
3,715
+4
+0.1% +$1.04K 0.05% 393
2021
Q3
$978K Sell
3,711
-1,238
-25% -$339K 0.05% 354
2021
Q2
$1.22M Buy
4,949
+14
+0.3% +$2.94K 0.07% 284
2021
Q1
$958K Buy
4,935
+123
+3% +$24.7K 0.07% 297
2020
Q4
$1.01M Sell
4,812
-1,537
-24% -$306K 0.07% 267
2020
Q3
$1.09M Buy
+6,349
New +$1.17M 0.09% 220

Other funds holding RMD

Kestra Private Wealth Services's RMD Position: Q2 2026 in Review

Kestra Private Wealth Services increased its ResMed (RMD) stake by 1.8% in Q2 2026, buying an estimated $17.8K and bringing the position to 4,819 shares worth $939K. The position accounts for 0.01% of the portfolio, ranked #934.

Kestra Private Wealth Services first reported a position in RMD in Q3 2020 and has held it in 24 quarters since. The position peaked at $2.24M in Q2 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Kestra Private Wealth Services held 4,819 shares of ResMed worth $939K as of Q2 2026.
  • Kestra Private Wealth Services bought 86 ResMed shares in Q2 2026, an estimated $17.8K.
  • ResMed made up 0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #934 holding.
  • Kestra Private Wealth Services first reported a position in ResMed in Q3 2020 and has held it in 24 quarters since.
  • Kestra Private Wealth Services's ResMed position peaked at $2.24M in Q2 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.